Difference between revisions of "Urothelium"

Jump to navigation Jump to search
66 bytes added ,  12:50, 19 October 2011
re-organize
(start re-working, re-org.)
(re-organize)
Line 60: Line 60:
**If the terminology in the urinary bladder were applied to the colon, we'd call all ''adenomas'', i.e. pre-malignant lesions, ''carcinomas''.
**If the terminology in the urinary bladder were applied to the colon, we'd call all ''adenomas'', i.e. pre-malignant lesions, ''carcinomas''.


=Specific entities=
=Overview in tables=
==General categorization==
Urothelial lesions can broadly be divided into:
Urothelial lesions can broadly be divided into:
#Flat lesions.
#Flat lesions.
Line 70: Line 71:
#*More often benign/indolent.
#*More often benign/indolent.


==Premalignant/Hyperplasic/Reactive changes==
===Flat urothelial lesions===
Several different benign/premalignant diagnoses can be made:
*Reactive atypia.
*Flat urothelial hyperplasia.
*Urothelial dysplasia.
 
Cancer:
*Urothelial carcinoma in situ.
*Invasive UCC.
 
Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:<ref>{{Ref GUP|155-163}}</ref>
Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:<ref>{{Ref GUP|155-163}}</ref>
{| class="wikitable"
{| class="wikitable"
Line 102: Line 94:
|}
|}
The '''bold''' entry is considered the key feature.
The '''bold''' entry is considered the key feature.
===Papillary urothelial lesions===
Urothelial cells in papillae - benign/premalignant/cancerous:<ref>{{Ref GUP|166-175}}</ref><ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
{| class="wikitable"
| ||'''Papilloma''' ||'''PUNLMP''' ||'''low grade PUCC''' ||'''high grade PUCC'''
|-
|papillae features ||'''fat papillae''', <br>'''thick FV core''' ||'''slender FV core''' ||slender FV core, <br>'''thick epithelium''' ||mixed population
|-
|papillae branching ||rare ||uncommon ||frequent ||common
|-
|papillae fusion ||none ||rare ||some ||common
|-
|nuclear size ||normal (2x lymphocyte) ||'''enlarged - uniform''' ||'''enlarged with variation''' ||'''4-5x lymphocyte,'''<br>'''marked pleomorphism'''
|-
|mitoses ||very rare basal || rare basal only ||infreq., usually basal ||common, everywhere
|-
|DDx ||PUNLMP, low gr. PUCC ||papilloma, low gr. ||PUNLMP, high gr. ||low gr., invasive UCC
|-
|IHC ||p53-, CK20+ umbrella cells ||CK20+ umbrella ||-/+ p53, CK20+ umbrella ||'''diffuse CK20+''', p53+ in 50%
|-
|Other ||cytologically normal ||low cellular density (@ low power) vs. low gr.<ref>GAG. 26 February 2009.</ref> ||+/- small nucleoli ||nucleoli prominent
|-
|Key feature ||normal cells,<br>fat papillae ||uniformly enlarged cell pop., <br>slender papillae ||nuc. pleomorphism, <br> thick epithelium ||marked nuclear pleomorphism
|-
|}
Notes:
*FV core = fibrovascular core.
*PUCC = papillary urothelial carcinoma.
=Specific entities=
==Premalignant/Hyperplasic/Reactive changes==
Several different benign/premalignant diagnoses can be made:
*Reactive atypia.
*Flat urothelial hyperplasia.
*Urothelial dysplasia.
Cancer:
*Urothelial carcinoma in situ.
*Invasive UCC.


==Risk factors for UCC==
==Risk factors for UCC==
Line 204: Line 235:
*[http://commons.wikimedia.org/wiki/File:Inverted_papilloma_high_mag.jpg Inverted papilloma - high mag. (WC)].
*[http://commons.wikimedia.org/wiki/File:Inverted_papilloma_high_mag.jpg Inverted papilloma - high mag. (WC)].
*[http://commons.wikimedia.org/wiki/File:Inverted_papilloma_intermed_mag.jpg Inverted papilloma - intermed. mag. (WC)].
*[http://commons.wikimedia.org/wiki/File:Inverted_papilloma_intermed_mag.jpg Inverted papilloma - intermed. mag. (WC)].
===Tabular comparison of papillary lesions===
Urothelial cells in papillae - benign/premalignant/cancerous:<ref>{{Ref GUP|166-175}}</ref><ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
{| class="wikitable"
| ||'''Papilloma''' ||'''PUNLMP''' ||'''low grade PUCC''' ||'''high grade PUCC'''
|-
|papillae features ||'''fat papillae''', <br>'''thick FV core''' ||'''slender FV core''' ||slender FV core, <br>'''thick epithelium''' ||mixed population
|-
|papillae branching ||rare ||uncommon ||frequent ||common
|-
|papillae fusion ||none ||rare ||some ||common
|-
|nuclear size ||normal (2x lymphocyte) ||'''enlarged - uniform''' ||'''enlarged with variation''' ||'''4-5x lymphocyte,'''<br>'''marked pleomorphism'''
|-
|mitoses ||very rare basal || rare basal only ||infreq., usually basal ||common, everywhere
|-
|DDx ||PUNLMP, low gr. PUCC ||papilloma, low gr. ||PUNLMP, high gr. ||low gr., invasive UCC
|-
|IHC ||p53-, CK20+ umbrella cells ||CK20+ umbrella ||-/+ p53, CK20+ umbrella ||'''diffuse CK20+''', p53+ in 50%
|-
|Other ||cytologically normal ||low cellular density (@ low power) vs. low gr.<ref>GAG. 26 February 2009.</ref> ||+/- small nucleoli ||nucleoli prominent
|-
|Key feature ||normal cells,<br>fat papillae ||uniformly enlarged cell pop., <br>slender papillae ||nuc. pleomorphism, <br> thick epithelium ||marked nuclear pleomorphism
|-
|}
Notes:
*FV core = fibrovascular core.
*PUCC = papillary urothelial carcinoma.


==Benign==
==Benign==
48,733

edits

Navigation menu